1. Home
  2. ZVRA vs SUPV Comparison

ZVRA vs SUPV Comparison

Compare ZVRA & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.81

Market Cap

689.4M

Sector

Health Care

ML Signal

HOLD

Logo Grupo Supervielle S.A. each Representing five Class B shares

SUPV

Grupo Supervielle S.A. each Representing five Class B shares

HOLD

Current Price

$7.66

Market Cap

703.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVRA
SUPV
Founded
2006
1887
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
689.4M
703.9M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
ZVRA
SUPV
Price
$9.81
$7.66
Analyst Decision
Strong Buy
Hold
Analyst Count
9
5
Target Price
★ $25.00
$11.80
AVG Volume (30 Days)
★ 744.9K
504.4K
Earning Date
11-03-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 159.21
N/A
EPS
★ 0.74
N/A
Revenue
★ $106,470,000.00
N/A
Revenue This Year
$43.97
$32.97
Revenue Next Year
$15.93
$20.17
P/E Ratio
$14.00
★ N/A
Revenue Growth
★ 350.91
N/A
52 Week Low
$8.01
$6.72
52 Week High
$15.04
$13.55

Technical Indicators

Market Signals
Indicator
ZVRA
SUPV
Relative Strength Index (RSI) 36.35 54.14
Support Level $9.29 $6.77
Resistance Level $11.19 $10.24
Average True Range (ATR) 0.46 0.31
MACD -0.03 0.09
Stochastic Oscillator 3.61 95.41

Price Performance

Historical Comparison
ZVRA
SUPV

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA a diversified financial services group in Argentina. It offers a broad range of financial products and services including lending, savings and investments, insurance, payments and cash management services, car loans, and asset management, positioning itself as a one-stop destination for financial needs. It operates exclusively in Argentina, through the Bank, which serves as its main banking subsidiary, delivering a comprehensive suite of financial services to retail, SMEs and corporate customers. Its segments include Personal & Business Banking; Corporate Banking; Bank Treasury; Insurance; and Asset Management and Other Services (which includes IOL invertironline). The majority of the revenue is derived from Personal & Business Banking segment.

Share on Social Networks: